PFM Health Sciences’s Jiya Acquisition Corp. Class A Common Stock JYAC Stock Holding History

PFM Health Sciences’s Portfolio JYAC Stock Details JYAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-464,103	Closed	-$4.63M	–	104
2022 Q3	$4.63M	Hold	464,103	–	–	0.17%	75
2022 Q2	$4.58M	Hold	464,103	–	–	0.17%	76
2022 Q1	$4.56M	Hold	464,103	–	–	0.17%	64
2021 Q4	$4.53M	Hold	464,103	–	–	0.15%	67
2021 Q3	$4.54M	Hold	464,103	–	–	0.13%	78
2021 Q2	$4.61M	Hold	464,103	–	–	0.14%	79
2021 Q1	$4.57M	Sell	464,103 -35,897	-7%	-$371K	0.14%	82
2020 Q4	$5.15M	Buy	+500,000	New	+$5.09M	0.18%	79

PFM Health Sciences's JYAC Position: Q4 2022 in Review

PFM Health Sciences sold out of Jiya Acquisition Corp. Class A Common Stock (JYAC) in Q4 2022, closing a stake of 464,103 shares — an estimated $4.63M sold.

PFM Health Sciences first reported a position in JYAC in Q4 2020 and held it in 8 quarters. The position peaked at $5.15M in Q4 2020. 0 funds tracked by Wall St. Rank hold JYAC as of Q4 2022.

PFM Health Sciences reported no remaining Jiya Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
PFM Health Sciences sold 464,103 Jiya Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $4.63M.
PFM Health Sciences first reported a position in Jiya Acquisition Corp. Class A Common Stock in Q4 2020 and held it in 8 quarters.
PFM Health Sciences's Jiya Acquisition Corp. Class A Common Stock position peaked at $5.15M in Q4 2020.
0 funds tracked by Wall St. Rank held Jiya Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on PFM Health Sciences's 13F filing for Q4 2022, filed 14 Feb 2023.